ADVANDX - Trademark Details
Status: 710 - Cancelled - Section 8
Serial Number
78208095
Registration Number
2837409
Word Mark
ADVANDX
Status
710 - Cancelled - Section 8
Status Date
2010-12-03
Filing Date
2003-01-28
Registration Number
2837409
Registration Date
2004-04-27
Mark Drawing
1000 - Typeset: Word(s)/letter(s)/number(s)
Typeset
Published for Opposition Date
2003-09-16
Law Office Assigned Location Code
M70
Employee Name
KON, ELISSA GARBER
Statements
Goods and Services
Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2010-12-03
Primary Code
005
First Use Anywhere Date
2002-05-01
First Use In Commerce Date
2003-04-07
Correspondences
Name
AdvanDx, Inc.
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2003-07-09 | ASSIGNED TO EXAMINER |
2003-07-09 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2003-08-27 | NOTICE OF PUBLICATION |
2003-09-16 | PUBLISHED FOR OPPOSITION |
2003-12-09 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2004-01-14 | TEAS STATEMENT OF USE RECEIVED |
2004-01-14 | USE AMENDMENT FILED |
2004-02-10 | STATEMENT OF USE PROCESSING COMPLETE |
2004-02-12 | ASSIGNED TO EXAMINER |
2004-02-12 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2004-04-27 | REGISTERED-PRINCIPAL REGISTER |
2010-12-03 | CANCELLED SEC. 8 (6-YR) |